Summary
Grapefruit juice has been reported to markedly improve the bioavailability of triazolam, midazolam, terfenadine, cyclosporine and several dihydropyridine calcium channel blockers including felodipine, nifedipine, nitrendipine and nisoldipine. Because these drugs are metabolized by the hepatic cytochrome P450 isozyme (CYP) 3A4, the inhibitory effect of grapefruit juice is thought to results from inhibition of CYP3A4. In this study, our aim was to investigate the effects of grapefruit juice on plasma concentrations of diazepam. Eight healthy male and female subjects participated in this study. Oral (5 mg) diazepam was administered with either 250 ml water and grapefruit juice. Blood samples were collected for a 24 h period, and whole blood concentrations of diazepam were measured enzyme immunoassay. The mean AUC(0−24) of diazepam was increased 3.2-fold (P<0.001) and Cmax was increased 1.5-fold (P<0.05) by the grapefruit juice. Grapefruit juice postponed the tmax of diazepam from 1.50 h to 2.06 h (P<0.01).
Similar content being viewed by others
References
Bailey D.G., Spence J.D., Munoz C., Amold J.M.O. (1991): Interaction of citrus grapefruit juice with felodipine and nifedipine. Lancet, 337, 268–269.
Bailey D.G., Arnold J.M.O., Munoz C., Spence J.D. (1993): Grapefruit juice-felodipine interaction: mechanism predictability and effect of naringin. Clin. Pharmacol. Ther., 53, 637–642.
Edgar B., Bailey D.G., Bergstrand R., Johnsson G., Regardh C.G. (1992): Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine and its potential clinical relevance. Eur. J. Clin. Pharmacol., 42, 313–317.
Rashid T.J., Martin U., Clarke H., Waller D.G., Renwick A.G., George C.F. (1995): Factors affecting the absolute bioavailability of nifedipine. Br. J. Clin. Pharmacol., 40, 51–58.
Siguch H., Hippius M., Henschel L., Kaufmann K., Hoffmann A. (1994): Influence of grapefruit juice on the pharmacokinetics of a slow release nifedipine formulation. Pharmazie, 49, 522–524.
Soons P.A., Voggels B.A.P.M., Roosemalen M.C.M. et al. (1991): Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans. Clin. Pharmacol. Ther., 50, 394–403.
Bailey D.G., Arnold J.M.O., Strong H.A., Munoz C., Spence J.D. (1993): Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clin. Pharmacol. Ther., 54, 589–594.
Benton R.E., Honig H.K., Zamani K., Cantilena L.R., Woosley L.R. (1996): Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram. Clin. Pharmacol. Ther., 59, 383–388.
Ducharme M.P., Warbasse L.H., Edwards D.J. (1995): Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin. Pharmacol. Ther., 57, 485–491.
Hollande A.A., Van Roois J. Lendjes G.V. et al. (1995): The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients. Clin. Pharmacol. Ther., 57, 318–324.
Kupperschmidt H.H.T., Ha R.H., Ziegler W.H., Meier P.S., Krahenbühl S. (1995): Interaction between grapefruit juice and midazolam in humans. Clin. Pharmacol. Ther., 58, 20–28.
Ha R.H., Chen J., Leuenberger P.M., Freiburghaus A.U., Follath F. (1995): In vitro inhibition of midazolam and quinidine metabolism by flavonoids. Eur. J. Clin. Pharmacol., 48, 367–371.
Hukkien S.K., Varhe A., Olkkola K., Neuvonen P.J. (1995): Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clin. Pharmacol. Ther., 58, 127–131.
Nemeroff C.B., De Vane C.L., Pollock B.G. (1996): Newer antidepressants and the cytochrome P450 system. Am. J. Psychiatry, 153, 311–320.
Guengerich F.P., Brian W.R., Iwasaki M., Sari M.A., Baarnhelm C., Berntsson P. (1991): Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P450IIIA4. J. Med. Chem., 34, 1838–1844.
Miniscalco A., Lundahl J., Regardh C., Edgar B., Eriksson G. (1992): Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J. Pharmacol. Exp. Ther., 261, 1195–1199.
Fuhr U., Klittich K., Staib A.H. (1993): Inhibitory effect of grapefruit juice its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br. J. Clin. Pharmacol. 35, 431–436.
Merkel U., Sigusch H., Hoffmann A. (1994): Grapefruit juice inhibits 7-hydroxylation of coumarin in healthy volunteers. Eur. J. Clin. Pharmacol., 46, 175–177.
Guengerich F.P., Shimada T., Yun C.H. et al. (1994): Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2, 2A6, 2E1 and 3A4 enzymes. Environ. Health Perspect., 9, 49–53.
De, Waziers, I., Cugnene P.H., Yang C.S., Leroux J.P., Baune P.H. (1990): Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J. Pharmacol. Exp. Ther., 253, 387–394.
Kronbach T., Mathyse D., Umeno M., Gonzales F.J., Meyer U.A. (1989): Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol. Pharmacol., 36, 89–96.
Fuhr U., Kummert, L.A. (1995): The fate of naringin in humans: a key to grapefruit juice-drug interactions. Clin. Pharmacol. Ther., 58, 365–373.
Guengerich F.P., Kim H.D. (1990): In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis, 11, 2275–2279.
Cresteil T., Monsarrat B., Alvinerie P., Treluyer J.M., Vieira I., Wright M. (1994): Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation. Cancer Res., 54, 386–392.
Gibaldi, M., Perrier D. (1982): Pharmacokinetics, 2nd Edn. New York: Marcel Dekker.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Özdemir, M., Aktan, Y., Boydaĝ, B.S. et al. Interaction between grapefruit juice and diazepam in humans. European Journal of Drug Metabolism and Pharmacokinetics 23, 55–59 (1998). https://doi.org/10.1007/BF03189827
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189827